| Hibbert, Benjamin |
| Recruiting | 4 | 346 | Canada, US | Dobutamine, Dobutrex, Inotrex, Milrinone, Normal Saline | Ottawa Heart Institute Research Corporation | Shock, Cardiogenic | 01/25 | 12/26 | | |
COBRRA AF, NCT04642430: COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation |
|
|
| Recruiting | 4 | 3018 | Canada | Apixaban, Eliquis, Rivaroxaban, Xarelto | Ottawa Hospital Research Institute, Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network, Canadian Institutes of Health Research (CIHR) | Atrial Fibrillation | 12/26 | 12/26 | | |
| Recruiting | 3 | 1800 | Canada | Rivaroxaban 15 MG Oral Tablet [Xarelto], Xarelto | Ottawa Heart Institute Research Corporation | Radial Artery Occlusion | 12/25 | 06/26 | | |
NCT04000607: Exploratory Study of the Edwards APTURE Transcatheter Shunt System (ALT-FLOW Canada) |
|
|
| Active, not recruiting | N/A | 45 | Canada | APTURE transcatheter shunt | Edwards Lifesciences | Heart Failure | 10/23 | 12/28 | | |
| Recruiting | N/A | 25 | Canada, US | MitraClip TMVR and Watchman LAAO | Mayo Clinic | Nonvalvular Atrial Fibrillation, Severe Degenerative Mitral Regurgitation | 01/26 | 01/26 | | |
| Withdrawn | N/A | 30 | Canada | Rivet Shunt | NXT Biomedical | Heart Failure, Pulmonary Hypertension | 05/24 | 05/25 | | |
SUMMIT, NCT03433274: Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation |
|
|
| Recruiting | N/A | 958 | Canada, US | Tendyne Mitral Valve System, MitraClip System | Abbott Medical Devices | Mitral Regurgitation, Mitral Insufficiency, Mitral Valve Insufficiency, Cardiovascular Diseases, Valve Disease, Heart, Heart Valve Diseases, Functional Mitral Regurgitation, Degenerative Mitral Valve Disease | 05/24 | 06/28 | | |
| Recruiting | N/A | 2650 | Europe, Canada, Japan, US, RoW | Left Atrial Appendage Occlusion (Amplatzer Amulet LAA Occluder), Amplatzer Amulet LAA Occluder, Non-Vitamin K Oral Antagonists, NOAC | Abbott Medical Devices | Atrial Fibrillation, Stroke, Bleeding | 08/27 | 08/30 | | |
| Recruiting | N/A | 144 | Canada, US | Transcatheter edge-to-edge repair, MitraClip, Medical therapy | Ottawa Heart Institute Research Corporation | Cardiogenic Shock, Mitral Regurgitation | 08/25 | 12/25 | | |
NCT05069558: Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion |
|
|
| Active, not recruiting | N/A | 450 | Europe, Canada, US | Investigational PFO Closure Device, Standard of Care PFO Closure Device | Occlutech International AB | Stroke, Patent Foramen Ovale, PFO | 11/25 | 10/26 | | |
| Recruiting | N/A | 500 | Europe, Canada, US | MitraClip™ device implantation, Mitral Valve Repair Surgery | Abbott Medical Devices | Mitral Valve Regurgitation | 04/26 | 04/34 | | |
| Ramirez, Daniel A |
COBRRA AF, NCT04642430: COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation |
|
|
| Recruiting | 4 | 3018 | Canada | Apixaban, Eliquis, Rivaroxaban, Xarelto | Ottawa Hospital Research Institute, Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network, Canadian Institutes of Health Research (CIHR) | Atrial Fibrillation | 12/26 | 12/26 | | |
2VIDA!, NCT05022472: Project COVID-19 Vaccine Intervention Delivery for Adults in Southern California |
|
|
| Completed | 4 | 1054 | US | COVID-19 Individual Awareness and Education., COVID-19 Community Outreach & Health Promotion., COVID-19 Individual Health Education & Linkages to Medical and Supportive Services., Pop-up community vaccination sites | Argentina Servin, MD, MPH, San Ysidro Health Center, National Institute on Minority Health and Health Disparities (NIMHD) | Vaccine Refusal, Covid19 | 03/24 | 03/24 | | |
| deWit, Kerstin |
COBRRA AF, NCT04642430: COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation |
|
|
| Recruiting | 4 | 3018 | Canada | Apixaban, Eliquis, Rivaroxaban, Xarelto | Ottawa Hospital Research Institute, Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) Network, Canadian Institutes of Health Research (CIHR) | Atrial Fibrillation | 12/26 | 12/26 | | |
